Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-290.98M
↓ 205% below average
Average (5y)
$-95.41M
Historical baseline
Range
High:$39.89M
Low:$-290.98M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-290.98M | -829.4% |
| 2023 | $39.89M | +119.9% |
| 2022 | $-200.85M | -143.1% |
| 2021 | $-82.64M | -111.9% |
| 2020 | $-39.00M | -3601.3% |
| 2019 | $1.11M | - |